Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Pulmonary Medicine|August 23, 2022
Altered expression of ACOX2 in non-small cell lung cancerJane S Y Sui, Petra Martin, Anna Keogh, et al.
Cancers|May 5, 2021
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLCGillian Moore, Clara Lightner, Samira Elbai, et al.
Cancers|March 28, 2026
An Analysis of G3BP2 in Non-Small Cell Lung CancerLeela S S Bandi, Leah Timon, Elena O'Toole, et al.
Cell Death Discovery|September 15, 2017
IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancerRyan A Hutchinson, Helen G Coleman, Kathy Gately, et al.
Biomedicines|September 28, 2023
An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)Ciara Murphy, Glòria Gornés Pons, Anna Keogh, et al.
Breast (Edinburgh, Scotland)|May 20, 2008
Breast cancer outcomes following a national initiative in Ireland to restructure delivery of services for symptomatic diseaseCatherine de Blacam, Jennifer Gray, Terence Boyle, et al.
Nature Protocols|June 12, 2021
Raman spectral cytopathology for cancer diagnostic applicationsDamien Traynor, Isha Behl, Declan O'Dea, et al.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|July 18, 2020
Lung cancer biomarker testing: perspective from EuropeErik Thunnissen, Birgit Weynand, Dalma Udovicic-Gagula, et al.
Pageof 3